| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.34B | 44.89B | 38.35B | 34.18B | 34.07B | 30.09B |
| Gross Profit | 10.03B | 10.36B | 9.75B | 8.30B | 7.71B | 6.89B |
| EBITDA | 5.72B | 5.08B | 6.82B | 4.58B | 3.91B | 2.97B |
| Net Income | 3.90B | 3.45B | 3.78B | 2.42B | 2.04B | 2.06B |
Balance Sheet | ||||||
| Total Assets | 80.60B | 83.08B | 82.70B | 82.02B | 70.98B | 67.30B |
| Cash, Cash Equivalents and Short-Term Investments | 9.19B | 12.01B | 12.91B | 13.84B | 14.87B | 17.34B |
| Total Debt | 5.00B | 5.00B | 5.06B | 5.04B | 21.00M | 34.00M |
| Total Liabilities | 21.15B | 19.80B | 22.68B | 21.71B | 14.67B | 12.92B |
| Stockholders Equity | 59.09B | 63.04B | 59.65B | 59.98B | 56.16B | 54.24B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.13B | -771.00M | -6.13B | -3.49B | 1.35B |
| Operating Cash Flow | 0.00 | 1.71B | 4.72B | -461.00M | 1.49B | 3.15B |
| Investing Cash Flow | 0.00 | 363.00M | -3.30B | -3.82B | -2.81B | -159.00M |
| Financing Cash Flow | 0.00 | -3.14B | -2.40B | 3.83B | -1.00B | -863.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥64.59B | 11.67 | ― | 3.95% | 2.75% | 25.75% | |
77 Outperform | ¥67.03B | 11.45 | ― | 2.79% | 4.22% | 7.91% | |
76 Outperform | ¥40.00B | 19.17 | ― | 2.53% | 4.16% | 1.16% | |
68 Neutral | ¥37.91B | 11.76 | ― | 3.32% | 17.04% | -5.21% | |
67 Neutral | ¥174.67B | 12.84 | 8.17% | 2.04% | 4.34% | 98.54% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥69.54B | 13.34 | ― | 3.09% | 7.43% | 47.68% |